02/14/2025
12:53 PM | Corvus Pharmaceuticals (Subject)
SAMLYN CAPITAL, LLC (Filed by)
| Form SCHEDULE 13G/A | |
01/13/2025
6:30 AM | Corvus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/23/2024
3:40 PM | Arcara Jeffrey (Reporting)
Corvus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/23/2024
3:38 PM | Corvus Pharmaceuticals (Issuer)
MILLER RICHARD A MD (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/23/2024
3:39 PM | Corvus Pharmaceuticals (Issuer)
LEA LEIV (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/23/2024
3:39 PM | Corvus Pharmaceuticals (Issuer)
Jones William Benton (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2024
6:30 AM | Corvus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/23/2024
3:11 PM | Corvus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/15/2024
11:15 PM | Corvus Pharmaceuticals (Filer)
| Form EFFECT | |
08/06/2024
4:31 PM | Corvus Pharmaceuticals (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
08/01/2024
8:18 PM | Corvus Pharmaceuticals (Subject)
SAMLYN CAPITAL, LLC (Filed by)
| Form SC 13G/A | |
Get the Latest News and Ratings for CRVS and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Corvus Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. |
06/17/2024
5:46 PM | Corvus Pharmaceuticals (Issuer)
Grais Linda (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
3:48 PM | CLARK IAN T (Reporting)
Corvus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
3:41 PM | Corvus Pharmaceuticals (Issuer)
Thompson Peter A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
3:43 PM | Corvus Pharmaceuticals (Issuer)
Gould Terry P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
3:44 PM | Corvus Pharmaceuticals (Issuer)
Morrison Scott W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2024
4:29 PM | Corvus Pharmaceuticals (Subject)
Point72 Asset Management, L.P. (Filed by)
| Form SC 13G | |
05/08/2024
7:28 PM | Corvus Pharmaceuticals (Issuer)
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP V LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/08/2024
7:34 PM | Corvus Pharmaceuticals (Issuer)
Thompson Peter A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/08/2024
6:55 PM | Corvus Pharmaceuticals (Subject)
ORBIMED ADVISORS LLC (Filed by)
| Form SC 13D/A | |
05/07/2024
4:16 PM | Corvus Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/07/2024
4:19 PM | Corvus Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
05/03/2024
3:05 PM | Corvus Pharmaceuticals (Filer)
| Form 424B5 | |
05/01/2024
4:06 PM | Corvus Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/01/2024
4:57 PM | Arcara Jeffrey (Reporting)
Corvus Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
